Comparison of Left Bundle Branch Area Versus Right Ventricular Septal Pacing in Patients With High-degree Conduction Disease After Transcatheter Aortic Valve Replacement (Left Bundle BRAVE)
Key facts
- Who runs it
- Main Line Health
- Where
- Overland Park, Philadelphia, Ridgewood, and Wynnewood, United StatesSee the 4 sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 46 people, planned
- Started
- 28 Dec 2022
- Ended
- 31 Dec 2025
- Type of study
- Interventional, 2 groups
- Treatments tested
- Right ventricular septal pacing followed by left bundle branch area pacing
- Left bundle branch area pacing followed by right ventricular septal pacing
- Record updated
- 10 December 2024
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Subject has at least one of these conduction disturbances:; Symptomatic (or hemodynamically significant) bradycardia or symptomatic persistent atrioventricular block including first-degree and Mobitz I (Wenckebach) or Mobitz type II atrioventricular bock; High-grade atrioventricular block; Third-degree atrioventricular block
- Subject has undergone TAVR (any valve system) in the last four weeks
- Subject is receiving a first-time pacemaker implant
- Subject's most recent documented ejection fraction (by any method) within the past 90 days prior to study enrollment is > 50% (≥45% if visually estimated at the time of enrollment)
- Subject is a male or female at least 18 years old at the time of consent
- Subject is able to receive a left sided pectoral implant
Who cannot take part
- Subject has ever had a previous or has an existing implantable pulse generator (IPG), implantable cardiac defibrillator (ICD) or biventricular (BiV) implant
- Subject is enrolled in a concurrent study that may confound the results of this study
- Subject has a mechanical heart valve
- Subject status post heart transplant
- Subject has LVEF < 45% if visually estimated at the time of enrollment
- Subject has more than mild para-valvular regurgitation following TAVR implantation
- Subject is indicated for a biventricular pacing device (CRT-P or CRT-D)
- Subject is pregnant, or of childbearing potential and not on a reliable form of birth control
- Subject life expectancy less than 2 years
Where in United States
- Kansas City Heart Rhythm InstituteOverland Park, United States
- Hospital of the University of PennsylvaniaPhiladelphia, United States
- Valley Health SystemRidgewood, United States
- Lankenau Medical CenterWynnewood, United States
About the trial
What the trial wants to find out
The purpose of the study is to investigate the superiority of chronic left bundle branch area pacing compared to traditional right ventricular (RV) septal pacing in patients with high-grade conduction disease after transcatheter aortic valve replacement (TAVR). In this investigator initiated, multicenter, prospective, double-blinded, crossover study, chronic left bundle branch area pacing will be compared to chronic right ventricular septal pacing using echocardiographic measures of left ventricular systolic function in patients with a high cumulative ventricular pacing burden after TAVR.
The 2 groups in the trial
- Group ATreatment being tested
Treatment: Right ventricular septal pacing followed by left bundle branch area pacing
- Group BTreatment being tested
Treatment: Left bundle branch area pacing followed by right ventricular septal pacing
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Comparison of Left Bundle Branch Area Versus Right Ventricular Septal Pacing in Patients With High-degree Conduction Disease After Transcatheter Aortic Valve Replacement
- Publications
- Record updated
- 10 December 2024